259 related articles for article (PubMed ID: 20688626)
1. Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review.
Yavropoulou MP; Kotsa K; Gotzamani Psarrakou A; Papazisi A; Tranga T; Ventis S; Yovos JG
Hormones (Athens); 2010; 9(3):274-8. PubMed ID: 20688626
[TBL] [Abstract][Full Text] [Related]
2. A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet.
Raeder H; Shaw N; Netelenbos C; Bjerknes R
Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S101-5. PubMed ID: 18775977
[TBL] [Abstract][Full Text] [Related]
3. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.
Alon US; Levy-Olomucki R; Moore WV; Stubbs J; Liu S; Quarles LD
Clin J Am Soc Nephrol; 2008 May; 3(3):658-64. PubMed ID: 18256372
[TBL] [Abstract][Full Text] [Related]
4. X-linked hypophosphataemic rickets: Report of a novel PHEX mutation and cinacalcet as adjuvant therapy in the mineral metabolism control.
Cavaco D; Amaro P; Simões-Pereira J; Pereira MC
Mod Rheumatol Case Rep; 2022 Jan; 6(1):145-149. PubMed ID: 34561702
[TBL] [Abstract][Full Text] [Related]
5. Successful management of tertiary hyperparathyroidism associated with hypophosphataemic rickets in an adult.
Anagnostis P; Vamvakidis K; Tournis S
J Musculoskelet Neuronal Interact; 2019 Sep; 19(3):370-373. PubMed ID: 31475945
[TBL] [Abstract][Full Text] [Related]
6. An unusual case of autonomous hyperparathyroidism in a patient with X-linked hypophosphatemic rickets and Kallmann syndrome.
Nabbout LA; Salti IS; Choucair MK
Am J Med Sci; 2009 Feb; 337(2):134-7. PubMed ID: 19214032
[TBL] [Abstract][Full Text] [Related]
7. Hypertension is a characteristic complication of X-linked hypophosphatemia.
Nakamura Y; Takagi M; Takeda R; Miyai K; Hasegawa Y
Endocr J; 2017 Mar; 64(3):283-289. PubMed ID: 28025445
[TBL] [Abstract][Full Text] [Related]
8. A mosaic mutation of phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) in X-linked hypophosphatemic rickets with mild bone phenotypes.
Asano S; Sako S; Funasaki Y; Takeshita Y; Niida Y; Takamura T
Endocr J; 2021 Sep; 68(9):1135-1141. PubMed ID: 33907069
[TBL] [Abstract][Full Text] [Related]
9. [X-linked hypophosphatemic rickets].
Michigami T
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):725-30. PubMed ID: 17506311
[No Abstract] [Full Text] [Related]
10. Switching from conventional therapy to burosumab injection has the potential to prevent nephrocalcinosis in patients with X-linked hypophosphatemic rickets.
Harada D; Ueyama K; Oriyama K; Ishiura Y; Kashiwagi H; Yamada H; Seino Y
J Pediatr Endocrinol Metab; 2021 Jun; 34(6):791-798. PubMed ID: 33837680
[TBL] [Abstract][Full Text] [Related]
11. X-Linked Hypophosphatemic Rickets: Multisystemic Disorder in Children Requiring Multidisciplinary Management.
Baroncelli GI; Mora S
Front Endocrinol (Lausanne); 2021; 12():688309. PubMed ID: 34421819
[TBL] [Abstract][Full Text] [Related]
12. Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets.
Makitie O; Toiviainen-Salo S; Marttinen E; Kaitila I; Sochett E; Sipila I
Horm Res; 2008; 69(4):212-20. PubMed ID: 18204268
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of patients with FGF23-related hypophosphatemic rickets.
Kinoshita Y; Saito T; Shimizu Y; Hori M; Taguchi M; Igarashi T; Fukumoto S; Fujita T
Eur J Endocrinol; 2012 Aug; 167(2):165-72. PubMed ID: 22577109
[TBL] [Abstract][Full Text] [Related]
14. Familial hypophosphatemic rickets caused by a large deletion in PHEX gene.
Saito T; Nishii Y; Yasuda T; Ito N; Suzuki H; Igarashi T; Fukumoto S; Fujita T
Eur J Endocrinol; 2009 Oct; 161(4):647-51. PubMed ID: 19581284
[TBL] [Abstract][Full Text] [Related]
15. Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets.
Li SS; Gu JM; Yu WJ; He JW; Fu WZ; Zhang ZL
Int J Mol Med; 2016 Dec; 38(6):1703-1714. PubMed ID: 27840894
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].
Jean G; Vanel T; Terrat JC; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Vovan C; Chazot C
Nephrol Ther; 2010 Apr; 6(2):105-10. PubMed ID: 20185380
[TBL] [Abstract][Full Text] [Related]
17. Effect of paricalcitol on circulating parathyroid hormone in X-linked hypophosphatemia: a randomized, double-blind, placebo-controlled study.
Carpenter TO; Olear EA; Zhang JH; Ellis BK; Simpson CA; Cheng D; Gundberg CM; Insogna KL
J Clin Endocrinol Metab; 2014 Sep; 99(9):3103-11. PubMed ID: 25029424
[TBL] [Abstract][Full Text] [Related]
18. A clinical and molecular genetic study of hypophosphatemic rickets in children.
Cho HY; Lee BH; Kang JH; Ha IS; Cheong HI; Choi Y
Pediatr Res; 2005 Aug; 58(2):329-33. PubMed ID: 16055933
[TBL] [Abstract][Full Text] [Related]
19. Novel PHEX gene mutation associated with X linked hypophosphatemic rickets.
Chandran M; Chng CL; Zhao Y; Bee YM; Phua LY; Clarke BL
Nephron Physiol; 2010; 116(3):p17-21. PubMed ID: 20664300
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of conventional phosphate and calcitriol treatment on metabolic recovery and catch-up growth in children with PHEX mutation.
Alikasifoglu A; Unsal Y; Gonc EN; Ozon ZA; Kandemir N; Alikasifoglu M
J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1573-1584. PubMed ID: 34525271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
